Genomics Platforms

1. Illumina NovaSeq 6000 Systems

   • Whole Genome Sequencing

   • Whole Exome Sequencing

   • RNA/Transcriptome Sequencing

2. ThermoFisher - Applied Biosystems 3730xl Genetic Analyzer

   • Sanger Sequencing

3. PacBio Sequel System

   • Long Read Sequencing

4. High-Resolution Microarray (1.6Kb)

5. Illumina Infinium Arrays

   • Genotyping

6. Methylation Sequencing

7. Single Cell Sequencing

   NovaSeq 6000 System and Infinium Arrays, 3730xl Genetic Analyzer, and Sequel System are trademarks of Illumina, PacBio and ThermoFisher Scientific, respectively.

Proteomics Platforms

1. Low-temperature protein sample process center established in Hong Kong

2. 7000-Protein simultaneous analysis capabilities - Testing performed at a U.S. CLIA-certified and CAP-accredited laboratory.

3. Determine multi-protein combined status allowing real-time health assessment and imminent disease risk characterization

4. Protein-based risks added to genomic-based risk enables a more accurate risk determination of a large number of human health abnormalities

Bioinformatics Platforms

1. Multiple Pipelines for Primary, Secondary and Tertiary Data Analysis

2. U.S., U.K. and Israeli Bioinformatics Platforms including:

   • Proprietary Algorithms

   • Artificial Intelligence

   • Natural Language Processors

   • Variant Classification Tools

   • Content Curation Tools

Analysis

Capabilities

• First round and confirmatory sequencing (See platforms above)

• Primary, secondary and tertiary data analysis

  • Whole Genome

  • Whole Exome

  • Transcriptome

  • Methylation

  • Pharmacogenomics

    • Adverse Drug Reaction

    • Drug-Drug Interaction

• Clinical Interpretation following ACMG guidelines

• Genetic Testing Services

  • Single Nucleotide Variant and Indel Analysis

  • Multi-Platform-based Variant Classifications

  • Copy Number Variant Analysis

  • Whole Genome-based Structural Variant Analysis

  • Deep Intronic and Mosaic Mutation Analysis

  • Repeat Expansion Detection and Analysis

  • Normal-Tumor Pair Analysis by Deep DNA and Transcriptome Sequencing

  • Polygenic Score Determination

  • Splice variant, intronic and mosaic mutation confirmation with confirmatory sequencing

  • Pharmacogenomics; Psycho-pharmacogenomics

• Content Curation

Baylor Genetics, an affiliate of the #1 NIH-funded genetics program at Baylor College of Medicine, has been a pioneer of precision medicine for nearly 40 years.

Juntendo University Medical School

The mission of Juntendo University is to strive for advances in society through education, research, and healthcare.

• Juntendo (Tokyo, Japan) was originally founded in 1838 as a Dutch School of Medicine at a time when Western medical education was not yet embedded as a normal part of Japanese society. Through the years the institution’s experience and perspective as an institution of higher education and a place of clinical practice has enabled Juntendo University to play an integral role in the shaping of Japanese medical education and practices.

• Rainbow partners with Juntendo’s clinical and genomic medicine teams at the Center of Intractable Disease Research,

  • The Juntendo medical team has many years of experience providing genetic testing to Asian patients. More importantly, the Japanese bioinformaticians and clinicians are trained to provide clinical interpretation specifically for Asian patients including Chinese and Japanese individuals.

Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

As a product of the Department of Molecular and Human Genetics at Baylor College of Medicine in collaboration with Baylor Genetics, Consultagene leverages the intellectual capital of the department's faculty, 180 members strong, and healthcare providers.